BMS-986183

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986183, covering 2019-01-30 to 2019-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer [Phase 1, Phase 2]